With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

The strategy of rewiring the brain's stress response is rooted in two pieces of scientific literature. One is biochemical.

Researchers also found that about one-third of teens undergoing weight-loss surgery had a body mass index (BMI) of more than ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

The Ozempic maker and its peers are setting their sights on oral obesity medications to diversify their portfolios and remain ...

This study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Weight-loss jabs have been hailed as the key to longer life even if you are not overweight, according to experts.

A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...